蓝帆医疗：心脑血管事业部2025年扭亏为盈，经营层面净利润超1亿元

Core Viewpoint - Blue Sail Medical aims to achieve profitability in its cardiovascular division by 2025, indicating a significant turnaround from previous losses [1] Financial Performance - The company reported a net profit exceeding 100 million yuan in operational terms after excluding the negative impact of over 100 million yuan from the fair value changes of its investment in Tongxin Medical [1] - This marks a substantial improvement from a loss of approximately 140 million yuan in 2024 to a profit of over 100 million yuan in 2025 [1]